Joylux Secures $4.5 Million in Funding to Expand Women’s Intimate Health Products and Partnership with Halle Berry

Joylux, a Seattle-based company specializing in women’s intimate health and wellness, has secured significant funding to expand its offerings. The company, which develops and markets home-use intravaginal products utilizing patent-pending light technology, recently raised $4.5 million in new capital. This latest round of funding brings the total amount raised by Joylux to $22 million.

The fresh capital will be used to launch Joylux’s partnership with actress, filmmaker, and entrepreneur Halle Berry, who is also an investor in the company. Berry, the founder of Respin, a women’s midlife wellness brand focused on women in menopause, discovered Joylux following a personal experience that left her searching for answers. She is helping promote a new Joylux intimacy gel called Let’s Spin.

Joylux’s products, including devices and accessory products, are carried by retail and health partners such as Nordstrom, Bloomingdales, Goop, Neiman Marcus, Ulta, and others. The company plans to grow with its international partner, Essity, a women’s health and hygiene corporation. Joylux sells a range of products, including gels, creams, cooling pads, and light therapy devices for the vagina, skin, breasts, hair, and nails.

The company’s direct-to-consumer business has seen significant growth, with a 162% year-over-year increase, according to Joylux CEO Colette Courtion. Joylux employs 15 people and has other notable backers, including Dr. Kathy Fields, a well-known dermatologist who co-created Proactiv and Rodan + Fields.

Joylux’s focus on women’s intimate health is part of a broader trend in the industry. The global menopause market size is estimated to grow to $600 billion, with more than a billion women expected to be in menopause by 2025. Historically, there has been little investment and innovation in this category, despite the staggering number of women impacted and dollars spent. According to a menopause survey conducted by AARP, 72% of women said menopausal symptoms had a negative impact on their lives, and 93% would be interested in non-hormonal solutions to help address these symptoms.

Joylux has been at the forefront of this market, introducing its vFit and vSculpt family of at-home vaginal health devices treating Genitourinary Syndrome of Menopause (GSM), a vaginal health condition that negatively impacts over 50% of women in menopause. Utilizing red-light LEDs and gentle heat, their patented and clinically-validated technology rebuilds collagen and elastin and increases blood flow in the vaginal tissue, resulting in dramatic improvement in GSM symptoms—less bladder leakage and vaginal dryness and improved sexual function—in less than 8 weeks.

In 2021, Joylux app-enabled the devices to provide personalized treatment plans, rich educational content, and community connection with other women struggling with these changes. Joylux devices and accessory products are now carried by over 1,000 medical professionals and retail partners such as Saks.com, Goop, and Neiman Marcus in the United States, Canada, and the United Kingdom.

The company’s partnership with Essity, the global leader in consumer health and hygiene products, will help fuel international growth. Essity’s Global Director of Menopause, Christine Arbelaez, noted that the category of menopause can be a multi-billion-dollar opportunity and expressed enthusiasm for introducing Joylux’s technology to consumers in Latin America and Europe.

Joylux’s CEO, Colette Courtion, emphasized the company’s commitment to addressing the health needs of menopausal women. “We are making aggressive moves to capitalize on the enormous market opportunity and health needs that menopause brings. Women want alternative treatment options to hormone replacement therapy, and we now have a platform of products that address a myriad of menopause health issues with non-hormonal solutions. Our newest app is proving to be an invaluable tool for women as they better understand what their bodies are going through. This cash infusion will bring more robust features and products to our platform, while increasing our brand footprint in new international markets with Essity as our partner.”